162 related articles for article (PubMed ID: 21464919)
21. HLA-DQB1*06 and breadth of Nef core region-specific T-cell response are associated with slow disease progression in antiretroviral therapy-naive Chinese HIV-1 subtype B patients.
Li W; Li C; Xia W; Li X
Hum Vaccin Immunother; 2017 Oct; 13(10):2341-2347. PubMed ID: 28771107
[TBL] [Abstract][Full Text] [Related]
22. Enhanced detection of human immunodeficiency virus type 1 (HIV-1) Nef-specific T cells recognizing multiple variants in early HIV-1 infection.
Malhotra U; Li F; Nolin J; Allison M; Zhao H; Mullins JI; Self S; McElrath MJ
J Virol; 2007 May; 81(10):5225-37. PubMed ID: 17329342
[TBL] [Abstract][Full Text] [Related]
23. HIV-1 Epitope Variability Is Associated with T Cell Receptor Repertoire Instability and Breadth.
Balamurugan A; Claiborne D; Ng HL; Yang OO
J Virol; 2017 Aug; 91(16):. PubMed ID: 28592539
[TBL] [Abstract][Full Text] [Related]
24. Characterization of Gag and Nef-specific ELISpot-based CTL responses in HIV-1 infected Indian individuals.
Mendiratta S; Vajpayee M; Malhotra U; Kaushik S; Dar L; Mojumdar K; Chauhan NK; Sreenivas V
Med Microbiol Immunol; 2009 Feb; 198(1):47-56. PubMed ID: 18985383
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.
Addo MM; Yu XG; Rathod A; Cohen D; Eldridge RL; Strick D; Johnston MN; Corcoran C; Wurcel AG; Fitzpatrick CA; Feeney ME; Rodriguez WR; Basgoz N; Draenert R; Stone DR; Brander C; Goulder PJ; Rosenberg ES; Altfeld M; Walker BD
J Virol; 2003 Feb; 77(3):2081-92. PubMed ID: 12525643
[TBL] [Abstract][Full Text] [Related]
26. Evolutionarily conserved epitopes on human immunodeficiency virus type 1 (HIV-1) and feline immunodeficiency virus reverse transcriptases detected by HIV-1-infected subjects.
Sanou MP; Roff SR; Mennella A; Sleasman JW; Rathore MH; Yamamoto JK; Levy JA
J Virol; 2013 Sep; 87(18):10004-15. PubMed ID: 23824804
[TBL] [Abstract][Full Text] [Related]
27. Translation of HLA-HIV associations to the cellular level: HIV adapts to inflate CD8 T cell responses against Nef and HLA-adapted variant epitopes.
Almeida CA; Bronke C; Roberts SG; McKinnon E; Keane NM; Chopra A; Kadie C; Carlson J; Haas DW; Riddler SA; Haubrich R; Heckerman D; Mallal S; John M
J Immunol; 2011 Sep; 187(5):2502-13. PubMed ID: 21821798
[TBL] [Abstract][Full Text] [Related]
28. An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais.
Bond KB; Sriwanthana B; Hodge TW; De Groot AS; Mastro TD; Young NL; Promadej N; Altman JD; Limpakarnjanarat K; McNicholl JM
AIDS Res Hum Retroviruses; 2001 May; 17(8):703-17. PubMed ID: 11429111
[TBL] [Abstract][Full Text] [Related]
29. Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein.
Couillin I; Culmann-Penciolelli B; Gomard E; Choppin J; Levy JP; Guillet JG; Saragosti S
J Exp Med; 1994 Sep; 180(3):1129-34. PubMed ID: 7520468
[TBL] [Abstract][Full Text] [Related]
30. CTL response to HIV type 1 subtype C is poorly predicted by known epitope motifs.
Ngandu NG; Bredell H; Gray CM; Williamson C; Seoighe C;
AIDS Res Hum Retroviruses; 2007 Aug; 23(8):1033-41. PubMed ID: 17725421
[TBL] [Abstract][Full Text] [Related]
31. Inter-clade cross-reactivity of HIV-1-specific T cell responses in human immunodeficiency virus type 1 infection in China.
Zhao S; Zhai S; Zhuang Y; Wang S; Huang D; Kang W; Li X; Yu XG; Walker BD; Altfeld MA; Sun Y
Curr HIV Res; 2007 Mar; 5(2):251-9. PubMed ID: 17346138
[TBL] [Abstract][Full Text] [Related]
32. Exploiting knowledge of immune selection in HIV-1 to detect HIV-specific CD8 T-cell responses.
Almeida CA; Roberts SG; Laird R; McKinnon E; Ahmad I; Keane NM; Chopra A; Kadie C; Heckerman D; Mallal S; John M
Vaccine; 2010 Aug; 28(37):6052-7. PubMed ID: 20619380
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development.
Cao H; Kanki P; Sankalé JL; Dieng-Sarr A; Mazzara GP; Kalams SA; Korber B; Mboup S; Walker BD
J Virol; 1997 Nov; 71(11):8615-23. PubMed ID: 9343219
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the human env-specific cytotoxic T-lymphocyte (CTL) response in natural human immunodeficiency virus type 1 infection: low prevalence of broadly cross-reactive env-specific CTL.
Carmichael A; Jin X; Sissons P
J Virol; 1996 Dec; 70(12):8468-76. PubMed ID: 8970969
[TBL] [Abstract][Full Text] [Related]
35. Preferential CTL targeting of Gag is associated with relative viral control in long-term surviving HIV-1 infected former plasma donors from China.
Jia M; Hong K; Chen J; Ruan Y; Wang Z; Su B; Ren G; Zhang X; Liu Z; Zhao Q; Li D; Peng H; Altfeld M; Walker BD; Yu XG; Shao Y
Cell Res; 2012 May; 22(5):903-14. PubMed ID: 22290423
[TBL] [Abstract][Full Text] [Related]
36. Human immunodeficiency virus type 1 specific cytotoxic T lymphocyte responses in Chinese infected with HIV-1 B'/C Recombinant (CRF07_BC).
Chen J; Hong K; Jia M; Liu H; Zhang Y; Liu S; Zhang X; Zhao H; Peng H; Ma P; Xing H; Ruan Y; Williams KL; Yu XG; Altfeld M; Walker BD; Shao Y
Retrovirology; 2007 Aug; 4():62. PubMed ID: 17727734
[TBL] [Abstract][Full Text] [Related]
37. HIV-1-specific cytotoxic T lymphocyte (CTL) responses against immunodominant optimal epitopes slow the progression of AIDS in China.
Zhai S; Zhuang Y; Song Y; Li S; Huang D; Kang W; Li X; Liao Q; Liu Y; Zhao Z; Lu Y; Sun Y
Curr HIV Res; 2008 Jun; 6(4):335-50. PubMed ID: 18691032
[TBL] [Abstract][Full Text] [Related]
38. Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target antigens.
Jassoy C; Harrer T; Rosenthal T; Navia BA; Worth J; Johnson RP; Walker BD
J Virol; 1993 May; 67(5):2844-52. PubMed ID: 7682629
[TBL] [Abstract][Full Text] [Related]
39. Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design.
Novitsky V; Rybak N; McLane MF; Gilbert P; Chigwedere P; Klein I; Gaolekwe S; Chang SY; Peter T; Thior I; Ndung'u T; Vannberg F; Foley BT; Marlink R; Lee TH; Essex M
J Virol; 2001 Oct; 75(19):9210-28. PubMed ID: 11533184
[TBL] [Abstract][Full Text] [Related]
40. Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo.
Haas G; Plikat U; Debré P; Lucchiari M; Katlama C; Dudoit Y; Bonduelle O; Bauer M; Ihlenfeldt HG; Jung G; Maier B; Meyerhans A; Autran B
J Immunol; 1996 Nov; 157(9):4212-21. PubMed ID: 8892659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
